Desmopressin Acetate Patent Expiration
Desmopressin Acetate was first introduced by Ferring Pharmaceuticals Inc
Desmopressin Acetate Patents
Given below is the list of patents protecting Desmopressin Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Noctiva | US11419914 | Safe desmopressin administration | Jun 15, 2030 | Acerus Pharms |
| Noctiva | US12090190 | Safe desmopressin administration | Jun 15, 2030 | Acerus Pharms |
| Noctiva | US9539302 | Safe desmopressin administration | Jun 15, 2030 | Acerus Pharms |
| Nocdurna | US9974826 | Methods comprising desmopressin | Apr 13, 2030 | Ferring Pharms Inc |
| Nocdurna | US10137167 | Methods comprising desmopressin | May 21, 2029 | Ferring Pharms Inc |
| Nocdurna | US11020448 | Methods comprising desmopressin | May 21, 2029 | Ferring Pharms Inc |
| Nocdurna | US11963995 | Methods comprising desmopressin | May 21, 2029 | Ferring Pharms Inc |
| Noctiva | US7799761 | Pharmaceutical compositions including low dosages of desmopressin |
Sep 26, 2024
(Expired) | Acerus Pharms |
| Nocdurna | US7560429 | Orodispersible dosage forms of desmopressin acetate |
Feb 02, 2024
(Expired) | Ferring Pharms Inc |
| Nocdurna | US7947654 | Pharmaceutical formulations |
Dec 29, 2023
(Expired) | Ferring Pharms Inc |
| Nocdurna | US8802624 | Methods of treatment using orodispersible desmopressin pharmaceutical formulations |
Dec 29, 2023
(Expired) | Ferring Pharms Inc |
| Nocdurna | US10307459 | Pharmaceutical formulations of desmopressin |
May 07, 2023
(Expired) | Ferring Pharms Inc |
| Nocdurna | US9220747 | Methods using desmopressin acetate in orodispersible form |
May 07, 2023
(Expired) | Ferring Pharms Inc |
| Nocdurna | US9504647 | Pharmaceutical formulations of desmopressin |
May 07, 2023
(Expired) | Ferring Pharms Inc |
| Nocdurna | US9919025 | Pharmaceutical formulations of desmopressin |
May 07, 2023
(Expired) | Ferring Pharms Inc |
| Noctiva | US7405203 | Pharmaceutical compositions including low dosages of desmopressin |
May 06, 2023
(Expired) | Acerus Pharms |
| Noctiva | US7579321 | Pharmaceutical compositions including low dosages of desmopressin |
May 06, 2023
(Expired) | Acerus Pharms |
| Ddavp | US7022340 | Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
Apr 30, 2023
(Expired) | Ferring Pharms Inc |
| Desmopressin Acetate | US7022340 | Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
Apr 30, 2023
(Expired) | Ferring |
| Ddavp | US5674850 | High purity desmopressin produced in large single batches |
Dec 23, 2013
(Expired) | Ferring Pharms Inc |
| Ddavp (needs No Refrigeration) | US5674850 | High purity desmopressin produced in large single batches |
Dec 23, 2013
(Expired) | Ferring Pharms Inc |
| Ddavp | US5500413 | Process for manufacture of 1-deamino-8-D-arginine vasopressin |
Jun 29, 2013
(Expired) | Ferring Pharms Inc |
| Ddavp | US5763407 | High-purity desmopressin produced in large single batches |
Jun 29, 2013
(Expired) | Ferring Pharms Inc |
| Ddavp (needs No Refrigeration) | US5482931 | Stabilized pharmaceutical peptide compositions |
Jun 29, 2013
(Expired) | Ferring Pharms Inc |
| Ddavp (needs No Refrigeration) | US5500413 | Process for manufacture of 1-deamino-8-D-arginine vasopressin |
Jun 29, 2013
(Expired) | Ferring Pharms Inc |
| Ddavp (needs No Refrigeration) | US5763407 | High-purity desmopressin produced in large single batches |
Jun 29, 2013
(Expired) | Ferring Pharms Inc |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Desmopressin Acetate's patents.
Latest Legal Activities on Desmopressin Acetate's Patents
Given below is the list recent legal activities going on the following patents of Desmopressin Acetate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Expire Patent Critical
| 30 Apr, 2018 | US7022340(Litigated) |
| Maintenance Fee Reminder Mailed Critical
| 13 Nov, 2017 | US7022340(Litigated) |
| Change in Power of Attorney (May Include Associate POA) Critical
| 30 May, 2014 | US7022340(Litigated) |
| Recordation of Patent Grant Mailed Critical
| 04 Apr, 2006 | US7022340(Litigated) |
| Patent Issue Date Used in PTA Calculation Critical
| 04 Apr, 2006 | US7022340(Litigated) |
| Issue Notification Mailed Critical
| 15 Mar, 2006 | US7022340(Litigated) |
| Dispatch to FDC | 03 Mar, 2006 | US7022340(Litigated) |
| Printer Rush- No mailing | 02 Feb, 2006 | US7022340(Litigated) |
| Mail Miscellaneous Communication to Applicant | 02 Feb, 2006 | US7022340(Litigated) |
| Miscellaneous Communication to Applicant - No Action Count | 31 Jan, 2006 | US7022340(Litigated) |
Desmopressin Acetate's Family Patents
